Caffeine Withdrawn Phase 1 Trials for Liver Diseases Basic Science

IndicationsStatusPurposePhase
WithdrawnBasic Science1
clinicaltrials.gov IdentifierTitleDrugs
NCT02098785Inhibition of VAP-1 by Caffeine in Healthy Human Volunteers Study